US Map / South Carolina
State SC

Clinical Trials in South Carolina

Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.

Total Trials
188
Recruiting Now
188
← Back to US Map
Top Conditions in South Carolina
Asthma (4)Opioid Use Disorder (4)Head and Neck Squamous Cell Carcinoma (3)Ulcerative Colitis (3)Cancer (3)Breast Cancer (3)Prostate Cancer (3)Alcohol Use Disorder (3)Cardiovascular Diseases (3)Hypertension (3)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)

Frequently Asked Questions — Clinical Trials in South Carolina

How many clinical trials are currently recruiting in South Carolina?
ClinicalMetric currently tracks 188 actively recruiting clinical trials with at least one location in South Carolina. The total number of registered studies—including active but not currently enrolling trials—is 188. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Carolina?
South Carolina hosts clinical trials across a broad range of medical conditions, including Asthma, Opioid Use Disorder, Head and Neck Squamous Cell Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Carolina?
To join a clinical trial in South Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in South Carolina

NCT06479681 N/A
Recruiting
A Peer Recovery Coaching Intervention for Hospitalized Alcohol Use Disorder Pati...
Condition
Alcohol Use Disorder
Enrollment
750 pts
Location
United States
Sponsor
Clemson University
View Trial →
NCT06496620 Phase 2
Recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Condition
COPD
Enrollment
171 pts
Location
United States, Australia, Canada
Sponsor
Uniquity One (UNI)
View Trial →
NCT06134232 Phase 2
Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + ...
Condition
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Enrollment
400 pts
Location
United States
Sponsor
Dendreon
View Trial →
NCT05281471 Phase 3
Recruiting
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Phy...
Condition
Platinum-resistant Ovarian Cancer
Enrollment
186 pts
Location
United States
Sponsor
Genelux Corporation
View Trial →
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07067463 Phase 3
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Condition
Multiple Sclerosis (MS) Primary Progressive
Enrollment
705 pts
Location
United States
Sponsor
Zenas BioPharma (USA), LLC
View Trial →
NCT06417385 N/A
Recruiting
taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge
Condition
Premature Birth
Enrollment
10 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT04176198 Phase 1, Phase 2
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Condition
Myelofibrosis
Enrollment
240 pts
Location
United States, Australia, Belgium
Sponsor
Sumitomo Pharma America, Inc.
View Trial →
NCT04914507 N/A
Recruiting
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Ant...
Condition
Scoliosis Idiopathic
Enrollment
106 pts
Location
United States, Canada
Sponsor
Pediatric Spine Foundation
View Trial →
NCT04333537 Phase 2, Phase 3
Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Pat...
Condition
Buccal Mucosa Squamous Cell Carcinoma
Enrollment
686 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT06959095 Phase 3
Recruiting
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Ob...
Condition
Pulmonary Disease, Chronic Obstructive
Enrollment
981 pts
Location
United States, China, Japan
Sponsor
GlaxoSmithKline
View Trial →
NCT04742894 N/A
Recruiting
Neural Bases of Vocal Sensorimotor Impairment in Aphasia
Condition
Aphasia
Enrollment
100 pts
Location
United States
Sponsor
The University of Texas at Dal
View Trial →
NCT06039566 Phase 3
Recruiting
NAC vs Placebo on Opioid Use for Hysterectomy
Condition
Hysterectomy
Enrollment
240 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT02235857 N/A
Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmen...
Condition
Focal Segmental Glomerulosclerosis
Enrollment
35 pts
Location
United States
Sponsor
Kaneka Medical America LLC
View Trial →
NCT07193511 Phase 1, Phase 2
Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Pati...
Condition
Solid Tumor Cancer
Enrollment
355 pts
Location
United States
Sponsor
Avenzo Therapeutics, Inc.
View Trial →
NCT06395389 N/A
Recruiting
A Brief Intervention for Cannabis Use
Condition
Cannabis Use Disorder
Enrollment
62 pts
Location
United States
Sponsor
Medical University of South Ca
View Trial →
NCT02991690 N/A
Recruiting
Systemic Hypothermia in Acute Cervical Spinal Cord Injury
Condition
Spinal Cord Injury, Acute
Enrollment
120 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07541417 N/A
Recruiting
Building Retention and Initiation Through Delivery of Peer-Guided Evidence-Based...
Condition
Opioid Use Disorder
Enrollment
750 pts
Location
United States
Sponsor
Prisma Health-Upstate
View Trial →
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
View Trial →
NCT06632457 Phase 3
Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a L...
Condition
Metabolic Dysfunction Associated Steatohepatitis
Enrollment
1,590 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT05892614 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patie...
Condition
Interstitial Lung Disease
Enrollment
25 pts
Location
United States
Sponsor
aTyr Pharma, Inc.
View Trial →
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07016477 N/A
Recruiting
Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT...
Condition
Coronary Artery Disease
Enrollment
1,000 pts
Location
United States, Germany, Hungary
Sponsor
Semmelweis University
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06423430 N/A
Recruiting
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Condition
Treatment Resistant Depression
Enrollment
100 pts
Location
United States
Sponsor
Abbott Medical Devices
View Trial →
Page 3 of 8 — 188 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology